ARCN1 and chlamydia trachomatis infectious disease: Recently, intranasal immunization with a mixture of three T3SS components, CopB, CopD, and CT584, with CpG resulted in the production of specific neutralizing antibodies and decreased chlamydial infection and Chlamydia-induced pathology [18].